Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ASTELLAS PHARMA INC [JP]”

28 pharma patents match "ASTELLAS PHARMA INC [JP]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 28
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 28 pharmaceutical patents matching "ASTELLAS PHARMA INC [JP]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

28 results for “ASTELLAS PHARMA INC [JP]” · 30,257 patents in full index Clear search

  1. LT 3254695

    COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

    ASTELLAS PHARMA INC [JP] · Granted Dec 28, 2020 · Expires Dec 23, 2040

    granted
  2. HR P20200591

    ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

    ASTELLAS PHARMA INC [JP] · Granted Jul 10, 2020 · Expires Jul 5, 2040

    granted
  3. US 2020199221

    ANTIBODIES USEFUL IN CANCER DIAGNOSIS

    ASTELLAS PHARMA INC [JP] · Granted Jun 25, 2020 · Expires Jun 20, 2040

    granted
  4. AU 2016249784

    Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis

    ASTELLAS PHARMA INC [JP] · Granted Nov 2, 2017 · Expires Oct 28, 2037

    granted